Boundless Bio | SC 13D:超過5%持股股東披露文件-ARCH Venture Fund IX, L.P.(12.1%),ARCH Venture Fund IX Overage, L.P.(12.1%)等
Boundless Bio | 3:首次持股聲明-高管 HINKLE DAVID A
Boundless Bio | 4:持股變動聲明-高管 Hassig Christian
Boundless Bio | 4:持股變動聲明-高管 Oien Jessica
Boundless Bio | 4:持股變動聲明-高管 Hornby Zachary
Boundless Bio | 4:持股變動聲明-高管 Abdollahian Neil
Boundless Bio | 4:持股變動聲明-高管 Wagner Klaus W.
Boundless Bio | 4:持股變動聲明-高管 Rubin Jami
Boundless Bio | 4:持股變動聲明-董事 Lim Jonathan E
Boundless Bio | SC 13G:超過5%持股股東披露文件-RA Capital Management, L.P.(9.8%),Peter Kolchinsky(9.8%)等
Boundless Bio | SC 13G:超過5%持股股東披露文件-Nextech VI Oncology SCSp(5.5%),Nextech VI GP S.à. r.l.(5.5%)等
Boundless Bio | SC 13G:超過5%持股股東披露文件-FMR LLC(14.673%),Abigail P. Johnson(14.673%)
Boundless Bio | SC 13G:超過5%持股股東披露文件-Bayer HealthCare LLC(7.3%),Bayer US Holding LP(7.3%)等
Boundless Bio | 4:持股變動聲明-股東 ARCH Venture Fund IX, L.P.
Boundless Bio | 4:持股變動聲明-股東 CRANDELL KEITH
Boundless Bio | 4:持股變動聲明-董事 Lim Jonathan E
Boundless Bio | 4:持股變動聲明-董事 Burow Kristina
Boundless Bio | 4:持股變動聲明-股東 RA CAPITAL MANAGEMENT, L.P.
Boundless Bio | 4:持股變動聲明-股東 Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Boundless Bio | 4:持股變動聲明-高管 Wagner Klaus W.
暫無數據
暫無數據